Global Drug Delivery Technologies Market Research Report 2023

Publication ID:

PB502240260

Publication Date:

February 20, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Drug Delivery Technologies market was valued at US$ 812990 million in 2022 and is anticipated to reach US$ 1133150 million by 2029, witnessing a CAGR of 5.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Drug Delivery Technologies is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Drug Delivery Technologies is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Drug Delivery Technologies in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Drug Delivery Technologies include Johnson & Johnson Services, Novartis, Roche, Pfizer, Bayer, Antares Pharma, Becton Dickinson, GlaxoSmithKline and Kindeva, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Technologies.
The Drug Delivery Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Delivery Technologies market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Johnson & Johnson Services
Novartis
Roche
Pfizer
Bayer
Antares Pharma
Becton Dickinson
GlaxoSmithKline
Kindeva
Merck
Sanofi
Segment by Type
Oral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Ocular Drug Delivery
Nasal Drug Delivery
Topical Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Segment by Application
Hospitals
Home Care Settings
Clinics
Diagnostic Centres
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Technologies companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Technologies Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral Drug Delivery
1.2.3 Pulmonary Drug Delivery
1.2.4 Injectable Drug Delivery
1.2.5 Ocular Drug Delivery
1.2.6 Nasal Drug Delivery
1.2.7 Topical Drug Delivery
1.2.8 Implantable Drug Delivery
1.2.9 Transmucosal Drug Delivery
1.3 Market by Application
1.3.1 Global Drug Delivery Technologies Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Home Care Settings
1.3.4 Clinics
1.3.5 Diagnostic Centres
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Technologies Market Perspective (2018-2029)
2.2 Drug Delivery Technologies Growth Trends by Region
2.2.1 Global Drug Delivery Technologies Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Delivery Technologies Historic Market Size by Region (2018-2023)
2.2.3 Drug Delivery Technologies Forecasted Market Size by Region (2024-2029)
2.3 Drug Delivery Technologies Market Dynamics
2.3.1 Drug Delivery Technologies Industry Trends
2.3.2 Drug Delivery Technologies Market Drivers
2.3.3 Drug Delivery Technologies Market Challenges
2.3.4 Drug Delivery Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Technologies Players by Revenue
3.1.1 Global Top Drug Delivery Technologies Players by Revenue (2018-2023)
3.1.2 Global Drug Delivery Technologies Revenue Market Share by Players (2018-2023)
3.2 Global Drug Delivery Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery Technologies Revenue
3.4 Global Drug Delivery Technologies Market Concentration Ratio
3.4.1 Global Drug Delivery Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Technologies Revenue in 2022
3.5 Drug Delivery Technologies Key Players Head office and Area Served
3.6 Key Players Drug Delivery Technologies Product Solution and Service
3.7 Date of Enter into Drug Delivery Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Technologies Breakdown Data by Type
4.1 Global Drug Delivery Technologies Historic Market Size by Type (2018-2023)
4.2 Global Drug Delivery Technologies Forecasted Market Size by Type (2024-2029)
5 Drug Delivery Technologies Breakdown Data by Application
5.1 Global Drug Delivery Technologies Historic Market Size by Application (2018-2023)
5.2 Global Drug Delivery Technologies Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug Delivery Technologies Market Size (2018-2029)
6.2 North America Drug Delivery Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug Delivery Technologies Market Size by Country (2018-2023)
6.4 North America Drug Delivery Technologies Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Technologies Market Size (2018-2029)
7.2 Europe Drug Delivery Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug Delivery Technologies Market Size by Country (2018-2023)
7.4 Europe Drug Delivery Technologies Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Technologies Market Size (2018-2029)
8.2 Asia-Pacific Drug Delivery Technologies Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug Delivery Technologies Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Delivery Technologies Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Technologies Market Size (2018-2029)
9.2 Latin America Drug Delivery Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug Delivery Technologies Market Size by Country (2018-2023)
9.4 Latin America Drug Delivery Technologies Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Technologies Market Size (2018-2029)
10.2 Middle East & Africa Drug Delivery Technologies Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug Delivery Technologies Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Delivery Technologies Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson Services
11.1.1 Johnson & Johnson Services Company Detail
11.1.2 Johnson & Johnson Services Business Overview
11.1.3 Johnson & Johnson Services Drug Delivery Technologies Introduction
11.1.4 Johnson & Johnson Services Revenue in Drug Delivery Technologies Business (2018-2023)
11.1.5 Johnson & Johnson Services Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Delivery Technologies Introduction
11.2.4 Novartis Revenue in Drug Delivery Technologies Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Drug Delivery Technologies Introduction
11.3.4 Roche Revenue in Drug Delivery Technologies Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Drug Delivery Technologies Introduction
11.4.4 Pfizer Revenue in Drug Delivery Technologies Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Drug Delivery Technologies Introduction
11.5.4 Bayer Revenue in Drug Delivery Technologies Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Antares Pharma
11.6.1 Antares Pharma Company Detail
11.6.2 Antares Pharma Business Overview
11.6.3 Antares Pharma Drug Delivery Technologies Introduction
11.6.4 Antares Pharma Revenue in Drug Delivery Technologies Business (2018-2023)
11.6.5 Antares Pharma Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Drug Delivery Technologies Introduction
11.7.4 Becton Dickinson Revenue in Drug Delivery Technologies Business (2018-2023)
11.7.5 Becton Dickinson Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Drug Delivery Technologies Introduction
11.8.4 GlaxoSmithKline Revenue in Drug Delivery Technologies Business (2018-2023)
11.8.5 GlaxoSmithKline Recent Development
11.9 Kindeva
11.9.1 Kindeva Company Detail
11.9.2 Kindeva Business Overview
11.9.3 Kindeva Drug Delivery Technologies Introduction
11.9.4 Kindeva Revenue in Drug Delivery Technologies Business (2018-2023)
11.9.5 Kindeva Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Drug Delivery Technologies Introduction
11.10.4 Merck Revenue in Drug Delivery Technologies Business (2018-2023)
11.10.5 Merck Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Drug Delivery Technologies Introduction
11.11.4 Sanofi Revenue in Drug Delivery Technologies Business (2018-2023)
11.11.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Johnson & Johnson Services
Novartis
Roche
Pfizer
Bayer
Antares Pharma
Becton Dickinson
GlaxoSmithKline
Kindeva
Merck
Sanofi

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂